Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaguire, Roma-
dc.contributor.authorCowie, Julie-
dc.contributor.authorLeadbetter, Clare-
dc.contributor.authorMcCall, Kathryn-
dc.contributor.authorSwingler, Kevin-
dc.contributor.authorMcCann, Lisa Ann-
dc.contributor.authorKearney, Nora-
dc.description.abstractPatients with breast cancer receiving chemotherapy are at risk of developing toxicities which can be severe or life threatening. The aim of this study was to develop and test a side effect risk modeling tool (ASyMS©-SERAT) for use in patients with breast cancer undergoing adjuvant chemotherapy. The study was conducted in two phases. Phase 1 entailed the development of the ASyMS©-SERAT tool using a secondary data set and in collaboration with an expert group of clinicians and an advisory group of patients. In phase 2, the predictive accuracy of the tool was measured using a prospective data set of 24 patients with breast cancer undergoing adjuvant chemotherapy. A high level of accuracy was reported for four of the six symptoms measured (>70%) supporting the future development and application of ASyMS©-SERAT in the prediction of chemotherapy-related toxicity. For patients, such information can be used to target information on side effects that they are likely to experience thereby facilitating the provision of tailored information based on their individual needs. For clinicians, knowing the likelihood of potential side effects can assist them in identifying patients who are at greater risk of developing certain toxicities, facilitating more targeted and cost-effective interventions.en_UK
dc.relationMaguire R, Cowie J, Leadbetter C, McCall K, Swingler K, McCann LA & Kearney N (2009) The development of a side effect risk assessment tool (ASyMS©-SERAT) for use in patients with breast cancer undergoing adjuvant chemotherapy, Journal of Research in Nursing, 14 (1), pp. 27-40.-
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.-
dc.subjectbreast canceren_UK
dc.subjectpredictive risk modellingen_UK
dc.subject.lcshCancer Research-
dc.subject.lcshCancer prevention-
dc.subject.lcshBreast Cancer Treatment-
dc.subject.lcshCancer Chemotherapy-
dc.titleThe development of a side effect risk assessment tool (ASyMS©-SERAT) for use in patients with breast cancer undergoing adjuvant chemotherapyen_UK
dc.typeJournal Articleen_UK
dc.rights.embargoreasonWe would like to delay access to this to article and request that the 'Request from author' option be added to this paper. The publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.-
dc.citation.jtitleJournal of Research in Nursing-
dc.type.statusPublisher version (final published refereed version)-
dc.contributor.affiliationCancer Care Research Centre-
dc.contributor.affiliationComputing Science and Mathematics-
dc.contributor.affiliationUniversity of Stirling-
dc.contributor.affiliationUniversity of Stirling-
dc.contributor.affiliationComputing Science - CSM Dept-
dc.contributor.affiliationCancer Care Research Centre-
dc.contributor.affiliationHS Research - Stirling-
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Maguire - The development of a side effect risk assessment tool.pdf320.21 kBAdobe PDFUnder Permanent Embargo    Request a copy

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.